NATCOPHARM.NS vs. ITC.NS

Last updated Jun 5, 2026

NATCOPHARM.NS (Natco Pharma Limited) and ITC.NS (ITC Limited) are both stocks. NATCOPHARM.NS operates in Drug Manufacturers - Specialty & Generic (Healthcare), while ITC.NS operates in Tobacco (Consumer Defensive). Over the past 10 years, NATCOPHARM.NS returned 6.58%/yr vs 5.83%/yr for ITC.NS. At a 0.18 correlation, their price movements are largely independent.

Performance

NATCOPHARM.NS vs. ITC.NS - Performance Comparison

The chart below illustrates the hypothetical performance of a ₹10,000 investment in Natco Pharma Limited (NATCOPHARM.NS) and ITC Limited (ITC.NS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NATCOPHARM.NS achieves a 1.91% return, which is significantly higher than ITC.NS's -27.05% return. Over the past 10 years, NATCOPHARM.NS has outperformed ITC.NS with an annualized return of 6.58%, while ITC.NS has yielded a comparatively lower 5.83% annualized return.

NATCOPHARM.NS

• 1D: -1.69%
• 1M: -18.34%
• YTD: 1.91%
• 6M: -3.05%
• 1Y: 7.58%
• 3Y*: 14.17%
• 5Y*: -1.76%
• 10Y*: 6.58%

ITC.NS

• 1D: 1.19%
• 1M: -7.55%
• YTD: -27.05%
• 6M: -27.06%
• 1Y: -29.50%
• 3Y*: -9.51%
• 5Y*: 11.90%
• 10Y*: 5.83%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NATCOPHARM.NS vs. ITC.NS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
NATCOPHARM.NS Natco Pharma Limited	1.91%	-34.53%	71.72%	46.21%	-37.35%	-5.57%	63.99%	-11.63%	-28.51%	67.49%
ITC.NS ITC Limited	-27.05%	-10.48%	8.22%	44.84%	59.50%	9.99%	-7.37%	-13.93%	9.11%	10.65%

Correlation

The correlation between NATCOPHARM.NS and ITC.NS is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.14
Correlation (10Y) Calculated over the trailing 10-year period	0.14
Correlation (All Time) Calculated using the full available price history since Jan 2, 1996	0.18

Return for Risk

NATCOPHARM.NS vs. ITC.NS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NATCOPHARM.NS

NATCOPHARM.NS Risk / Return Rank: 46
NATCOPHARM.NS Sharpe Ratio Rank: 49
NATCOPHARM.NS Sortino Ratio Rank: 43
NATCOPHARM.NS Omega Ratio Rank: 43
NATCOPHARM.NS Calmar Ratio Rank: 49
NATCOPHARM.NS Martin Ratio Rank: 48

ITC.NS

ITC.NS Risk / Return Rank: 2
ITC.NS Sharpe Ratio Rank: 0
ITC.NS Sortino Ratio Rank: 2
ITC.NS Omega Ratio Rank: 2
ITC.NS Calmar Ratio Rank: 5
ITC.NS Martin Ratio Rank: 2

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NATCOPHARM.NS vs. ITC.NS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Natco Pharma Limited (NATCOPHARM.NS) and ITC Limited (ITC.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NATCOPHARM.NS	ITC.NS	Difference
Sharpe ratio: Return per unit of total volatility	0.20	-1.55	+1.75
Sortino ratio: Return per unit of downside risk	0.55	-2.12	+2.67
Omega ratio: Gain probability vs. loss probability	1.07	0.72	+0.35
Calmar ratio: Return relative to maximum drawdown	0.32	-0.92	+1.24
Martin ratio: Return relative to average drawdown	0.57	-1.73	+2.29
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NATCOPHARM.NS vs. ITC.NS - Sharpe Ratio Comparison

The current NATCOPHARM.NS Sharpe Ratio is 0.20, which is higher than the ITC.NS Sharpe Ratio of -1.55. The chart below compares the historical Sharpe Ratios of NATCOPHARM.NS and ITC.NS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NATCOPHARM.NS	ITC.NS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.20	-1.55	+1.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.05	0.61	-0.66
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.20	0.25	-0.05
Sharpe Ratio (All Time) Calculated using the full available price history	0.28	0.53	-0.24

Drawdowns

NATCOPHARM.NS vs. ITC.NS - Drawdown Comparison

The maximum NATCOPHARM.NS drawdown since its inception was -89.98%, which is greater than ITC.NS's maximum drawdown of -55.28%. Use the drawdown chart below to compare losses from any high point for NATCOPHARM.NS and ITC.NS.

Drawdown Indicators

	NATCOPHARM.NS	ITC.NS	Difference
Max Drawdown Largest peak-to-trough decline	-89.98%	-55.28%	-34.70%
Max Drawdown (1Y) Largest decline over 1 year	-23.82%	-31.96%	+8.14%
Max Drawdown (3Y) Largest decline over 3 years	-53.00%	-40.29%	-12.71%
Max Drawdown (5Y) Largest decline over 5 years	-54.29%	-40.29%	-14.00%
Max Drawdown (10Y) Largest decline over 10 years	-55.44%	-55.28%	-0.16%
Current Drawdown Current decline from peak	-41.82%	-39.58%	-2.24%
Average Drawdown Average peak-to-trough decline	-35.81%	-15.12%	-20.69%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.36%	17.07%	-3.71%

Volatility

NATCOPHARM.NS vs. ITC.NS - Volatility Comparison

Natco Pharma Limited (NATCOPHARM.NS) has a higher volatility of 18.16% compared to ITC Limited (ITC.NS) at 5.49%. This indicates that NATCOPHARM.NS's price experiences larger fluctuations and is considered to be riskier than ITC.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NATCOPHARM.NS	ITC.NS	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.16%	5.49%	+12.67%
Volatility (6M) Calculated over the trailing 6-month period	29.61%	17.30%	+12.31%
Volatility (1Y) Calculated over the trailing 1-year period	38.00%	18.98%	+19.02%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	34.09%	19.96%	+14.13%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	34.21%	23.84%	+10.37%

Dividends

NATCOPHARM.NS vs. ITC.NS - Dividend Comparison

NATCOPHARM.NS's dividend yield for the trailing twelve months is around 0.54%, less than ITC.NS's 5.17% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ITC.NS ITC Limited	5.17%	3.56%	2.95%	3.48%	3.60%	5.12%	5.04%	2.51%	1.90%	1.87%	2.44%	1.98%
NATCOPHARM.NS Natco Pharma Limited	0.54%	0.55%	0.41%	1.17%	1.11%	0.39%	0.91%	1.18%	1.25%	0.75%	0.35%	0.17%

Financials

Frequently Asked Questions

Can I hold both NATCOPHARM.NS and ITC.NS in my portfolio?

NATCOPHARM.NS and ITC.NS have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.